A trial of 2 strategies to reduce nocturnal blood pressure in blacks with chronic kidney disease

Mahboob Rahman, Tom Greene, Robert A. Phillips, Lawrence Y. Agodoa, George L. Bakris, Jeanne Charleston, Gabriel Contreras, Francis Gabbai, Leena Hiremath, Kenneth Jamerson, Cynthia Kendrick, John W. Kusek, James P. Lash, Janice Lea, Edgar R. Miller, Stephen Rostand, Robert Toto, Xulei Wang, Jackson T. Wright, Lawrence J. Appel

Research output: Contribution to journalArticle

41 Scopus citations

Abstract

The objective of our study was to determine the effects of 2 antihypertensive drug dose schedules (PM dose and add-on dose) on nocturnal blood pressure (BP) in comparison with usual therapy (AM dose) in blacks with hypertensive chronic kidney disease and controlled office BP. In a 3-period, crossover trial, former participants of the African American Study of Kidney Disease were assigned to receive the following 3 regimens, each lasting 6 weeks, presented in random order: AM dose (once-daily antihypertensive medications taken in the morning), PM dose (once-daily antihypertensives taken at bedtime), and add-on dose (once-daily antihypertensives taken in the morning and an additional antihypertensive medication before bedtime [diltiazem 60-120 mg, hydralazine 25 mg, or additional ramipril 5 mg]). Ambulatory BP monitoring was performed at the end of each period. The primary outcome was nocturnal systolic BP. Mean age of the study population (n=147) was 65.4 years, 64% were men, and mean estimated glomerular filtration rate was 44.9 mL/min per 1.73 m. At the end of each period, mean (SE) nocturnal systolic BP was 125.6 (1.2) mm Hg in the AM dose, 123.9 (1.2) mm Hg in the PM dose, and 123.5 (1.2) mm Hg in the add-on dose. None of the pairwise differences in nocturnal, 24-hour, and daytime systolic BP was statistically significant. Among blacks with hypertensive chronic kidney disease, neither PM (bedtime) dosing of once-daily antihypertensive nor the addition of drugs taken at bedtime significantly reduced nocturnal BP compared with morning dosing of antihypertensive medications.

Original languageEnglish (US)
Pages (from-to)82-88
Number of pages7
JournalHypertension
Volume61
Issue number1
DOIs
StatePublished - Jan 1 2013

Keywords

  • chronic kidney disease
  • hypertension
  • nocturnal blood pressure

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint Dive into the research topics of 'A trial of 2 strategies to reduce nocturnal blood pressure in blacks with chronic kidney disease'. Together they form a unique fingerprint.

  • Cite this

    Rahman, M., Greene, T., Phillips, R. A., Agodoa, L. Y., Bakris, G. L., Charleston, J., Contreras, G., Gabbai, F., Hiremath, L., Jamerson, K., Kendrick, C., Kusek, J. W., Lash, J. P., Lea, J., Miller, E. R., Rostand, S., Toto, R., Wang, X., Wright, J. T., & Appel, L. J. (2013). A trial of 2 strategies to reduce nocturnal blood pressure in blacks with chronic kidney disease. Hypertension, 61(1), 82-88. https://doi.org/10.1161/HYPERTENSIONAHA.112.200477